Data / Drug companies / P & L Development, LLC
P & L Development, LLC: 81 products in the FDA NDC directory, labeler code 59726
P & L Development, LLC (labeler code 59726) lists 81 products in the FDA National Drug Code Directory, covering 23 finished drugs by generic name. By type: 68 over the counter drugs, 13 bulk ingredients. Its main marketing category is generic drugs (ANDA). The newest product started marketing on August 15, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 59726
- Products in commercial distribution
- 81
- Packages
- 135
- Finished drugs by generic name
- 23
- Prescription products
- 0
- Over the counter products
- 68
- Flagged as original packager
- 64 of 64 products that carry the flag
- Started marketing in the last 12 months
- 6
- Products with a marketing end date set
- 19
- Earliest marketing start
- March 31, 2016
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 43 | 53.1% |
| Over the counter monograph drugs | 25 | 30.9% |
| Bulk ingredients for compounding | 13 | 16% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 68 | 84% |
| Bulk ingredients | 13 | 16% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Nicotine polacrilex | 8 | 57 |
| Ibuprofen | 7 | 190 |
| Docusate sodium | 7 | 79 |
| Docosanol | 5 | 42 |
| Minoxidil | 5 | 113 |
| Simethicone | 3 | 86 |
| Diphenhydramine hcl | 3 | 99 |
| Cetirizine hcl | 3 | 48 |
| Omeprazole | 3 | 106 |
| Acetaminophen | 2 | 214 |
| Guaifenesin | 2 | 123 |
| Aspirin | 2 | 134 |
| Acetaminophen, aspirin, caffeine | 2 | 48 |
| Fexofenadine hcl | 2 | 39 |
| Docusate sodium and sennosides | 2 | 29 |
| Fluticasone propionate | 2 | 71 |
| Naproxen sodium | 2 | 100 |
| Guaifenesin, dextromethorphan hbr | 1 | 26 |
| Acetaminophen, dextromethorphan hbr, phenylephrine hcl | 1 | 45 |
| Diclofenac sodium | 1 | 109 |
| Miconazole nitrate | 1 | 101 |
| Adapalene | 1 | 34 |
| Acetaminophen diphenhydramine hcl | 1 | 7 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, liquid filled | 18 | 22.2% |
| Gum, chewing | 17 | 21% |
| Tablet, coated | 8 | 9.9% |
| Tablet | 6 | 7.4% |
| Cream | 6 | 7.4% |
| Capsule | 6 | 7.4% |
| Aerosol, foam | 5 | 6.2% |
| Lozenge | 4 | 4.9% |
| Tablet, delayed release | 3 | 3.7% |
| Tablet, extended release | 2 | 2.5% |
| Gel | 2 | 2.5% |
| Spray, metered | 2 | 2.5% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Fluticasone Propionate | 59726-350 | Spray, metered | Generic drugs (ANDA) | August 15, 2026 |
| Aspirin | 59726-103 | Tablet, coated | Over the counter monograph drugs | August 15, 2026 |
| Ibuprofen | 59726-003 | Tablet, coated | Generic drugs (ANDA) | August 15, 2026 |
| Pain Reliever | 59726-113 | Chewable gel | Over the counter monograph drugs | June 30, 2026 |
| Headache Relief Extra Strength | 59726-586 | Tablet, coated | Over the counter monograph drugs | June 20, 2026 |
| Allergy Relief | 59726-203 | Spray, metered | Generic drugs (ANDA) | May 15, 2026 |
| Omeprazole | 59726-744 | Tablet, delayed release | Generic drugs (ANDA) | August 29, 2025 |
| Omeprazole | 59726-740 | Tablet, delayed release | Generic drugs (ANDA) | August 15, 2025 |
| Nicotine Mini | 59726-652 | Lozenge | Generic drugs (ANDA) | June 1, 2025 |
| Nicotine | 59726-650 | Lozenge | Generic drugs (ANDA) | June 1, 2025 |
| Mucus Relief | 59726-237 | Tablet, extended release | Generic drugs (ANDA) | February 15, 2025 |
| Omeprazole | 59726-298 | Tablet, delayed release | Generic drugs (ANDA) | January 31, 2025 |
| Cold Sore Fever Blister | 59726-221 | Cream | Generic drugs (ANDA) | January 31, 2025 |
| Mucus Relief | 59726-734 | Tablet, extended release | Generic drugs (ANDA) | December 6, 2024 |
| Ibuprofen | 59726-279 | Capsule, liquid filled | Generic drugs (ANDA) | December 1, 2024 |
| Nicotine polacrilex | 59726-428 | Gum, chewing | Bulk ingredients for compounding | November 30, 2024 |
| Nicotine polacrilex | 59726-613 | Gum, chewing | Bulk ingredients for compounding | October 22, 2024 |
| Nicotine polacrilex | 59726-612 | Gum, chewing | Bulk ingredients for compounding | October 22, 2024 |
| Nicotine polacrilex | 59726-609 | Gum, chewing | Bulk ingredients for compounding | October 22, 2024 |
| Nicotine polacrilex | 59726-608 | Gum, chewing | Bulk ingredients for compounding | October 22, 2024 |
| Nicotine polacrilex | 59726-605 | Gum, chewing | Bulk ingredients for compounding | October 22, 2024 |
| Nicotine polacrilex | 59726-503 | Gum, chewing | Bulk ingredients for compounding | October 22, 2024 |
| Nicotine polacrilex | 59726-499 | Gum, chewing | Bulk ingredients for compounding | October 22, 2024 |
| Nicotine polacrilex | 59726-496 | Gum, chewing | Bulk ingredients for compounding | October 22, 2024 |
| Nicotine polacrilex | 59726-482 | Gum, chewing | Bulk ingredients for compounding | October 22, 2024 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.